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Abstract
The effectiveness of stem-cell therapies has been hampered by cell death and limited control over 
fate1. These problems can be partially circumvented by using macroporous biomaterials that 
improve the survival of transplanted stem cells and provide molecular cues to direct cell 
phenotype2–4. Stem cell behavior can also be controlled in vitro by manipulating the elasticity of 
both porous and non-porous materials5–7, yet translation to therapeutic processes in vivo remains 
elusive. Here, by developing injectable, void-forming hydrogels that decouple pore formation from 
elasticity, we show that mesenchymal stem cell (MSC) osteogenesis in vitro, and cell deployment 
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in vitro and in vivo, can be controlled by modifying, respectively, the hydrogel's elastic modulus or 
its chemistry. When the hydrogels were used to transplant MSCs, the hydrogel's elasticity 
regulated bone regeneration, with optimal bone formation at 60 kPa. Our findings show that 
biophysical cues can be harnessed to direct therapeutic stem-cell behaviors in situ.
Keywords
Cell Delivery; Cell Therapy; Porogen; Mechanotransduction
Endogenous stem cell niches provide an optimal micro-environment for stem cell 
maintenance, and also facilitate stem cell deployment in response to host injury4,8 . One 
particular niche component, the extracellular matrix (ECM), has been identified as a 
particularly important source of cues that direct cell fate decisions. Biomaterials have been 
designed to mimic these niches by presenting specific signaling cues to modulate stem cell 
expansion, migration and gene expression2–4,9. Biophysical aspects of the ECM, including 
elasticity, have been linked to a variety of cellular behaviors in vitro and in vivo using 
hydrogel systems5,6,10. However, current materials used to manipulate cell fate via matrix 
elasticity (e.g. mechanotransduction) in 3D limit cell motility, proliferation or new tissue 
formation6,11. Materials used to elicit tissue formation via transplanted cells must also 
degrade to allow space for new tissue formation12,13. Unlike materials used to study 
mechanobiology in vitro, these transplantable, degradable scaffolds typically exhibit 
mechanical properties that change continuously over time, making it difficult to study 
relationships between matrix mechanics and cell behavior. Slowly degrading macroporous 
sponges fabricated from polymers such as poly(lactide-co-glycolide) exhibit a structure 
compatible with tissue ingrowth14, but these protein-fouling materials do not allow precise 
control of the cell-material interface, making it difficult to control transplanted cell behavior 
through defined insoluble cues.
To address the limitations of current materials, we developed void-forming hydrogels. 
Within these materials, cells are initially encapsulated into a nanoporous hydrogel milieu 
that subsequently form pores in situ, after injection into host tissues. Current techniques used 
to create macroporous biomaterials rely on extraction of porogen templates by 
solvents 7,15,16, in situ degradation of soft materials17, phase inversion 18, cell-mediated 
degradation of single phase hydrogels19, or 3D printing20. A significant drawback of 
scaffold-based methods is that they typically do not allow simple delivery of the material via 
injection. While enzymatically degradable, single-phase hydrogel materials offer elegant 
control over cellular invasion, cell confinement within these systems remains strongly 
coupled to matrix elasticity, and enzyme-mediated changes to local mechanical properties 
may be difficult to control in a pre-determined manner. Exogenous mechanical stimulation 
of cells in 3D culture alters their Matrix Metalloproteinase (MMP) activity21, suggesting it is 
likely that mechanotransduction pathways triggered by the interaction of cellular contractile 
forces and matrix elasticity will also alter MMP activity in these hydrogel systems. In turn, 
this may make it difficult to decouple matrix elasticity from micron-scale cellular protrusion 
into the material.
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We hypothesized that the aforementioned drawbacks could be overcome with a system 
wherein solid-phase porogens could be first encapsulated into a bulk hydrogel, but then 
degrade via hydrolysis, resulting in the creation of voids within the hydrogels after 
placement in physiologic conditions (fig. 1a). Importantly, the rate of pore formation and 
subsequent cell release, endogenous cell infiltration and tissue formation would then be 
controlled by the rate of porogen degradation and cell migration and proliferation within 
pores. This would decouple the elasticity of the slowly degrading, “bulk” component (fig. 
1a, grey) from cell confinement by the gel, with the rate of void-formation and cell release 
pre-determined via the chemical composition of porogens. Furthermore, these composite 
materials could be introduced into the body in a minimally invasive manner as long as the 
porogens within were smaller than the diameter of the injection needle.
To test the possibility of fabricating void-forming hydrogels, mechanically rigid, but rapidly 
degrading sacrificial gel porogens of an appropriate size (~150µm diameter; fig. S1) were 
formed from oxidized, hydrolytically labile alginate22, and encapsulated into a “bulk” 
hydrogel comprised of slowly degrading, high molecular weight alginate (fig 1b,S1). To 
assess the possibility of void formation in situ, we first performed scanning electron 
microscopy on composite gels that were flash-frozen in liquid nitrogen at different time-
points after formation. These studies suggested time-dependent void-formation (fig. S2), but 
because of concerns about artifactual pore formation during freezing and lyophilization, we 
developed a fluorescence assay to directly analyze void-formation within intact hydrogels 
(fig. 1b). Simultaneous in situ fluorescence analysis of the porogens (green) and bulk 
component (red) of void-forming hydrogels revealed that porogens were initially intact, but 
degraded in-situ to form voids (fig. 1b). Quantifying the kinetics of porogen degradation 
revealed a time-scale of approximately one week for the majority of porogen degradation 
(fig. 1c,d). Consistent with these studies, rheological analysis of the shear modulus G’ of 
these composite materials seven days after formation indicated a porogen-density dependent 
decrease in G’ in void-forming hydrogels, as compared to intact, standard hydrogels (not 
containing porogen) at day 0 (fig. 1e). When the density of pores was above 50%, the 
relationship between pore concentration and the decrease of G’ was nearly linear (fig. 1e), 
consistent with theoretical predictions of the mechanical behavior of pore-filled solids23.
The effects of pore formation on encapsulated cell morphology and distribution within the 
void-forming hydrogels were next analyzed. Clonally derived mouse mesenchymal stem 
cells (mMSC; D1, ref. 24) were used as a cell model. Previous studies involving non-porous 
hydrogels indicate these cells and human MSC exhibit similar responses to matrix 
composition, but that D1 demonstrate less spontaneous osteogenic differentiation than 
primary human MSC6.25. The bulk phase of hydrogels was modified with peptides which 
present the integrin binding RGD motif, to provide a defined mechanism for cell adhesion26, 
and the density of porogens was held constant at 50% of the total volume of void-forming 
hydrogels. The overall morphology of mMSC was initially similar in standard and void-
forming hydrogels. In contrast, after void formation, cells adjacent to pores exhibited 
extended distended, spread morphology (fig. 1f), whereas cells in standard hydrogels, or 
those that were far from the pore phase within void-forming hydrogels, maintained a 
rounded morphology consistent with past reports6,27. Apparent changes in cell morphology 
were verified with phalloidin staining (fig. 1g). Over longer time-frames, pore formation led 
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to enhanced cellularity and the presence of large cell clusters spanning significant distances 
within the composite material (fig. 1f). This increase in apparent cellularity, although partly 
caused by morphology changes, was also due to cell proliferation. Proliferation could be 
controlled based on the dose of RGD presented by the bulk component of void forming 
hydrogels (fig. 1h-j). As cell encapsulation into alginate hydrogels is highly efficient and 
does not depend on RGD density (data not shown), these results indeed reflect the influence 
of RGD on cell proliferation (rather than initial cell density).
Given the ability to form void-forming hydrogels, and the interest in applying these 
materials to test the ability to use matrix elasticity to control transplanted cell behavior, we 
next performed in vitro studies to determine the effects on MSCs of modulating the elasticity 
of the RGD-modified bulk phase. At a fixed density of RGD peptides (375µM) previously 
established to induce osteogenesis of hMSC in 3D culture6, and a porogen volume density of 
50%, mMSC proliferation and osteogenic commitment were analyzed (fig. 2). Cell 
proliferation exhibited a biphasic dependence on matrix elasticity, peaking within materials 
of intermediate stiffness (fig. 2a). Osteogenic lineage commitment, assessed via Alkaline 
Phosphatase (ALP) activity in deployed cells, was also optimal with intermediate bulk 
matrix elasticity (fig. 2b). These findings are consistent with previous work which indicated 
high levels of integrin occupancy occurred in 3D materials with intermediate elastic 
modulus6. Consistent with previous literature linking cell-matrix mechanics to 
differentiation of pre-osteoblasts28, we observed a marked effect of matrix elasticity on 
Mitogen Activated Protein Kinase (MAPK) signaling, as assessed by MAPK Thr202/Tyr204 
phosphorylation within cells remaining in void-forming hydrogels after seven days of 
culture (fig. 2c,d). To further verify the effect of bulk component elasticity on osteogenic 
behavior of encapsulated MSC, more definitive markers of osteogenesis were assessed. 
Collagen I expression and mineralization by mMSC both occurred within void-forming 
hydrogels in an elasticity-dependent manner (fig. 2e-g). These results are consistent with 
previous studies involving non-porous, RGD-modified cell encapsulating hydrogels, which 
indicated a biphasic effect of E on osteogenesis6, in materials that prevented cell migration 
and also limited proliferation. Normalizing collagen I expression to cell number did reveal a 
subtle effect of proliferation on total osteogenesis (fig. 2h) – however, the biphasic 
relationship between matrix elasticity and osteogenic marker expression was preserved.
As the elasticity of the cell-interactive phase of void-forming hydrogels could be tuned to 
modulate MSC osteogenesis, we next investigated the application of these materials for cell 
deployment in vitro, to test their potential ability to support transplanted cell deployment 
and ingrowth of newly formed endogenous tissue. As cell deployment was expected to occur 
via channels of interconnected voids spanning from the surface through the interior of the 
material, initial studies were performed to determine the minimum density of porogens 
required (Supplemental Materials). For infinitely large composite gels, a percolating 
network of porogens would be required, and this would lead to a minimum porogen volume 
fraction near 65%. However, given the ultimate size of gels used in these studies (2mm 
diameter for in vitro studies, with injection volumes of 100µL for in vivo studies), and the 
size of porogens (~150µm diameter), numerical simulations predicted effective percolation 
of voids (e.g. high likelihood of voids spanning through the material) with porogen fraction 
of 50%. Although a volume fraction of 50% porogens was not sufficient for interconnected 
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void-formation as assessed by a capillary assay (Supplemental Materials, fig. S3), it was 
more than sufficient to allow cell release. Because this lower porogen volume fraction (50%) 
facilitated specimen handling, particularly with void-forming gels with a soft bulk 
component, this porogen density was used in all subsequent analyses.
The dependence of cell deployment kinetics on porogen material properties was next 
investigated. Cell deployment was monitored by measuring alamar blue reduction by cells 
that had deployed out of gels, onto the underlying plastic substrate, after verifying that this 
methodology produced similar estimates of cell release as direct, manual counts (fig. S3b). 
Pore formation led to substantial cell deployment from void-forming hydrogels, whereas 
little release occurred from standard gels with the same composition as the bulk component 
of void-forming hydrogels (fig. 3a). The total number of cells deployed exceeded the 
number of cells initially encapsulated in the void-forming hydrogels, consistent with our 
previous observation of cell proliferation within these materials (fig. 1h-j). Importantly, the 
kinetics of deployment and overall number of released cells could also be controlled by 
manipulating two porogen fabrication parameters: the concentration of hydrolytically labile 
groups in the polymers used to form porogens, and the concentration of divalent cation used 
to crosslink porogens (fig. 3b,c). At a constant porogen density and RGD density (375µM, 
the same density used for in vitro osteogenesis assays), increasing the bulk gel elasticity 
diminished cell deployment (fig. 3d). Diminished cell release from materials with higher 
elastic moduli may reflect a higher adhesivity that prevents cell detachment29, or an inability 
of the cells to deform the gels sufficiently to enable their migration through the material to 
access the pores7. Interestingly, net cell deployment from void-forming hydrogels with 
constant bulk component elasticity (60 kPa) was not affected by RGD density (fig. 3e). This 
is in contrast to previous work linking cell-ECM adhesiveness to cell migration speed29. The 
apparent discrepancy between these results may result from changes in cell migration speed 
being matched by changes in cell proliferation, which substantially increased as the density 
of RGD peptides was raised from 0 to 750µM. Based on this finding, it is most likely that 
modulating bulk matrix elasticity affected cell release by altering cells’ ability to 
mechanically deform the hydrogel surrounding voids, as they migrate through the composite 
material.
Cell deployment from void-forming hydrogels in vivo was analyzed using genetically 
labeled cells within hydrogels transplanted subcutaneously in nude mice. In the first week 
following cell transplantation, there was a slight (30%) decrease in the fluorescent signal 
from the mCherry-labeled mMSC for all transplantation conditions. Following this slight 
decrease, mMSC delivered within standard, nanoporous hydrogels were released to a modest 
extent, but only after several weeks (fig. 3f,g; S4), achieving a final density about 9.5-fold as 
high as at day 7. However, mMSC delivered within void-forming hydrogels were released 
much more rapidly and proliferated markedly, over the same time-scale on which pores 
formed, finally achieving a 31-fold increase over the density at day 7. Consistent with in 
vitro studies, both the overall number of mMSC and the kinetics of their deployment from 
pore-forming gels could be controlled by modulating porogen characteristics (fig. 3g). 
Further, the number of deployed cells increased substantially when the density of peptides in 
the bulk gel was increased (fig. 3h). Finally, within a cranial defect model, the generation of 
voids spanning the material and concomitant mMSC release could be detected histologically 
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within one week of cell encapsulation within void-forming hydrogels (fig. 3i). Cells released 
from these void-forming hydrogels were found at distances up to 350µm away from the gels. 
In contrast, mMSC were retained in standard hydrogels (fig. 3j).
As void-forming hydrogels could control MSC deployment, differentiation and proliferation 
in vitro, as well as expansion and dissemination of cells in vivo, we next investigated 
whether these materials could be used to enhance the effects of transplanted MSC on bone 
regeneration. Human MSC (hMSC), either in saline, standard hydrogels, or void-forming 
hydrogels were directly injected into freshly formed critically-sized cranial defects in nude 
rats. Both standard and void-forming hydrogels had constant bulk composition (150µM 
RGD, 60 kPa), which was chosen to match the properties of hydrogels previously 
demonstrated to elicit ectopic bone formation in vivo by encapsulated osteoblasts and 
chondrocytes30. Bone growth was evaluated 12 weeks after cell transplantation. Paralleling 
results from clinical studies involving direct stem cell transplantation1, bolus delivery of 
hMSC alone in the nude rat model had only modest effects on bone regeneration, as 
measured by micro-computed tomography (fig. 4a,b).
Transplantation of hMSC within standard, nanoporous hydrogels improved bone 
regeneration compared to the bolus injection group (fig. 4b, S5). hMSC transplantation 
within void-forming hydrogels led to a further, statistically significant increase in the 
amount of new bone formation, compared to cells alone (fig. 4a,b). Histologic analysis 
revealed that when hMSC were delivered via saline bolus, much of the newly formed bone 
was near the margin of the original defect, likely reflecting ingrowth of tissue adjacent the 
defect, rather than new bone formation (fig. S5). Delivery with nanoporous gels led to large 
masses of hydrogel remaining in the defect site, and the osteogenic tissue that had formed in 
this condition was often contained within the remaining hydrogel and not in continuity with 
host tissues (fig. S5).
Compared to standard hydrogels, void-forming gels left a much smaller amount of 
remaining gel material 12 weeks following transplantation (fig. S5), and analysis of 
trichrome stained sections also revealed the presence of osteoblasts emanating from the 
small fragments of residual material in void-forming gels near the center of defects, 
consistent with the assumption that cells that directly interact with the material contributed 
to new bone formation (fig. S5). To determine the origin of the newly generated bone, we 
performed fluorescence in situ hybridization (FISH) studies to detect the primate specific 
Alu repeat mRNA sequence, on samples obtained after 4 weeks. Although mineralization 
had already occurred at this time point, it was less extensive than at 12 weeks, making FISH 
analysis feasible. At four weeks, although there were clearly detectable human cells 
remaining within both standard and void-forming hydrogels, the vast majority of cells were 
non-primate (rodent) in origin (fig. S5). These results suggest that transplanted cells either 
served as a source of osteogenic cytokines, or recruited endogenous rodent cells, which 
subsequently interacted with the gel to form bone. This hypothesis may be testable via 
implantation of acellular hydrogels, either with or without cytokine loading. However, 
precisely matching cell-mediated cytokine delivery in terms of specific proteins and kinetics 
may prove challenging31.
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Finally, studies were performed to test the hypothesis that matrix elasticity regulates bone 
formation by transplanted stem cells. Strikingly, new bone formation exhibited a marked 
dependence on bulk matrix elasticity, with optimal regeneration occurring within materials 
with an intermediate elastic modulus (60 kPa; fig. 4c-f). The volume of new bone generated 
with void-forming gels that did not exhibit this optimal elastic modulus was not statistically 
different compared to bone generated by transplanting cells in saline (fig. 4a).
The effect of matrix elasticity on bone regeneration was found at 12 weeks, although the 
modulus of the material would be expected to diminish slightly by this time. This finding is 
consistent with previous data suggesting that MSC commit during their first 1–2 weeks in a 
mechanically optimal micro-environment, even if the mechanical cues vary after that time5,6. 
Moreover, MSC-derived cells that were cultured under these osteo-permissive 3D conditions 
in vitro were previously shown to elaborate osteogenic cytokines such as osteocalcin6, and 
this may have contributed to fate decisions within transplanted hMSC and stimulation of 
bone formation by endogenous cells. µCT analysis of the bone mineral density and 
trichrome staining of tissue sections also suggested that the quality of newly formed bone 
was greatest at the intermediate bulk gel stiffness (fig. 4e-g). Finally, trichrome staining of 
sections derived from defects into which hMSC were delivered from hydrogels of optimal 
elasticity revealed newly formed bone with entrapped cells and osteoblasts on the bone 
surfaces, suggesting that tissue formation within the defect site mimics hallmarks of 
endogenous bone formation (fig. 4h-j).
The elastic modulus found in these studies to best induce bone formation and stimulate 
defect repair is similar to the optimal range found to induce osteogenic gene and protein 
expression in encapsulated MSC in nanoporous gels in vitro6. This suggests that 
mechanotransduction pathways that regulate stem cell gene and protein expression in vitro 
might be directly transferred to complex in vivo processes such as bone formation. Because 
the pore size of hydrogels used in that previous work were not permissive to cell migration 
or marked expansion, this result further suggests that at least part of the contribution of 
matrix elasticity to new bone formation is directly related to mechanically-induced 
osteogenesis, and not simply secondary to cells’ ability to egress from gels. Furthering this 
notion that migration was not the sole determinant of mechanically-controlled bone 
formation in the present study was our in vitro observation that MSC deployment was most 
pronounced in void-forming gels with a bulk component elasticity near 5 kPa – a range that 
was not compatible with new bone growth. Nevertheless, the bone repair we observed likely 
required some cell migration and proliferation and the ability of hydrogels with elasticity in 
the 60 kPa range to support these processes (based on in vitro assays, fig. 2a,b, 3d) was also 
likely important for transplanted cell-mediated tissue repair.
Previous in vitro work has demonstrated that with hydrogels that exhibit a high degree of 
swelling, changes in nanometer-scale ligand distribution resulting from changes in substrate 
crosslinking may have a more pronounced effect on MSC behavior than do corresponding 
changes in matrix elasticity32. However, the results of the current study and other work with 
similar hydrogels that exhibit more limited changes in swelling, ligand density and 
nanometer-scale adhesion ligand distribution as elastic modulus is altered demonstrate direct 
effects of E on stem cell behavior6,33,34. Recently developed materials in which secondary 
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crosslinks can be formed in situ, or in which crosslinks can be degraded in situ, in the 
presence of cells, offer an elegant experimental approach to study temporal requirements for 
matrix elasticity to control cellular mechanotransduction in vitro11, 35,36; however, causing 
void-formation on the size-scales required for cellular deployment out of, and infiltration 
into these types of gels in vivo would require novel methodologies for precisely delivering 
light into tissues.
Here, we demonstrate that mechanotransduction, previously shown to regulate mesenchymal 
stem cell fate in vitro5,6, and implicated in craniofacial development37, can be harnessed to 
locally control stem cell mediated tissue repair in situ. Given the strong evidence that 
mechanotransduction pathways regulate a variety of other stem cell populations in vitro33,38, 
we anticipate that these biophysical cues might be useful in regenerating other tissues. The 
optimal stiffness found to induce new bone growth in the present studies is slightly higher 
than that reported for in vitro osteogenesis in nanoporous 3D gels. However, MSCs near a 
newly formed pore likely experience a slightly diminished modulus compared to the 
stiffness sensed in nanoporous hydrogels39, and this may underlie the small discrepancy. The 
finding that bone regeneration was initiated in the absence of exogenous growth factors 
suggests that these mechanotransduction pathways act synergistically with low basal 
endogenous levels of osteogenic cytokines37,40. Importantly, this suggests that optimally 
designed materials could be used to obtain highly localized control over transplanted cell 
fate, preventing deleterious off-target effects that have previously been observed when high 
levels of locally administered osteogenic cytokines can diffuse out of the intended 
application area41.
Given the promise of harnessing mechanotransduction toward transplanted-cell mediated 
tissue repair, it will be important in future studies to define early changes in signaling and 
transcription networks that underlie later, functional changes in cell fate. In the present work, 
we identified a strong correlation between MAPK signaling and in vitro osteogenesis. 
However, the exact optimum for MAPK signaling (20 kPa) at day 7 differs from the 
optimum we observed for ALP activity and per-cell Collagen I expression (60 kPa) at day 
14. This suggests the potential need to glean quantitative information on multiple signaling 
pathways, over multiple time-points to predict matrix-guided MSC fate42. Likewise, precise 
identification of the timing of activation of osteogenic transcription factors (e.g. Runx2, 
Osterix) would allow one to thoroughly explore the large variable space (elasticity, adhesion 
ligand density, rate of void formation, etc.) and identify optimal design parameters that 
induce the most efficient cell-mediated tissue repair.
We anticipate that void-forming hydrogels will provide a useful platform for future basic 
studies on cell-matrix interactions and translational studies involving cell therapies. Both the 
bulk hydrogel and porogen phases of these materials could be utilized in future work to 
deliver soluble cues to enhance regeneration. These materials could also be used to deliver 
inhibitory molecules (e.g. function blocking antibodies) in order to probe the molecular 
mechanisms through which cell-material interactions, or cellular interactions with host 
tissues, modify the fate of transplanted and endogenous cells43. Although not explored in the 
present work, the effects of biomaterial pore size on tissue formation and cell migration has 
been studied extensively in the past7, and altering porogen size may facilitate enhanced 
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control over endogenous cell recruitment in future studies. Furthermore, if the degradation 
properties of the bulk material are modified to yield more permanent structures (for 
example, by incorporating covalent rather than ionic crosslinking), these injectable materials 
may be useful towards preserving the survival and phenotype of human cells transplanted in 
the context of humanized models of in vivo stem cell niches (e.g. bone marrow; ref. 44). In 
contrast to materials that require surgical implantation or that mediate significant protein 
adsorption (e.g., poly(lactide-co-glycolide)), hydrogel materials used to fabricate void-
forming gels may be less likely to induce inflammation or other processes that might 
interfere with the biology being analyzed. By uncoupling several biophysical cues shown to 
regulate cell fate in vitro – including porosity, matrix elasticity and matrix adhesivity7, the 
strategy used to fabricate void-forming hydrogels allows these variables to be independently 
tuned to control cell fate. The ability to harness these cues in situ will likely be useful for 
cell-based therapies, as well as basic studies on the biology of cell-matrix interactions in 
vivo.
Methods Summary
Void-Forming Hydrogels
To form the rapidly degrading porogen phase, high Mw, high guluronic acid (GA)-content 
alginates (MVG; FMC biopolymer) were modified by oxidation of between 3–7.5% of GA 
residues with sodium periodate (Sigma; ref. 21). Following dialysis, sterile filtration and 
lyophilization, binary mixtures of oxidized MVG combined with high Mw, unmodified 
MVG were dissolved into serum free Dulbecco’s Modified Eagle Media (DMEM; 
Invitrogen). Polymer solutions were formed into gel beads by extruding through a glass 
atomizer with co-axial nitrogen air flow at a constant pressure (30 mmHg) into a bath of 25–
100mM calcium chloride in 50–100mM HEPES buffer (pH 7.4) with constant stirring. After 
5 minutes of crosslinking, gel beads were retrieved, and washed to deplete excess calcium. 
In some cases, alginate polymers used to form porogens were labeled with aminofluorescein 
(Sigma; ref. 45) to facilitate analysis of porogen size and shape.
To form the slowly degrading, cell-interactive bulk gel phase, MVG alginates were 
covalently coupled with the integrin binding peptide (Gly)4-Arg-Gly-Asp-Ala-Ser-Ser-Lys-
Tyr (Peptides International; ref. 26). In studies involving the effects of bulk gel elastic 
modulus on cells, RGD-modified MVG was combined with unmodified MVG or MVG that 
had been irradiated to reduce Mw but maintain crosslinking ability (ref. 46). Void-forming 
hydrogels were formed by encapsulating cells and porogens into the bulk gel phase, and then 
crosslinking the bulk-gel phase with calcium sulfate. In some experiments, MVG used to 
form the bulk gel was labeled with tetramethylrhodamine cadaverine (Anaspec).
In vitro Osteogenesis Assays
Clonally derived derived mouse mesenchymal stem cells (D1; ref. 24, American Type Cell 
Culture, used at passages 20–24) were encapsulated into the bulk gel phase (20 million 
cells/mL of bulk gel, to mimic the density that would eventually be used for cranial defect 
studies) by mixing with polymer before addition of porogen beads and crosslinking. 
Immediately after crosslinking, composite hydrogels were transferred to tissue culture 
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polystyrene substrates with DMEM containing 10% Fetal Bovine Serum and 1% Penicillin/
Streptomycin. To facilitate osteogenesis, 50µg/mL L-ascrobic acid and 10mM β-glycerol 
phosphate were also added to the media, which was exchanged every two days. At 7 and 14 
days, hydrogels were transferred aseptically to fresh media in a fresh tissue culture plate. 
Care was taken to avoid damaging hydrogels during transfer. After moving gels on day 14, 
wells in the used plate were washed with PBS and then adherent cells were lysed into a 
passive lysis buffer (Promega). The nuclear and cytosolic fractions were next separated by 
centrifugation (14,000g, 20 minutes). DNA was liberated from the nuclear pellet (CyQuant 
lysis buffer, Invitrogen), and quantitated with Hoescht 33342, based on a standard curve 
generated with calf thymus DNA. Alkaline phosphatase (ALP) activity of the cytosolic 
fraction was quantitated with 4-MUP reagent (Sigma), with a standard curve provided by 
Calf Intestine Alkaline Phosphatase (Sigma). In parallel with these studies, void-forming 
gels containing cells were fixed at day 14, first in paraformaldehyde (to fix cells) and then in 
barium chloride, to fix hydrogels. Samples were then embedded into Optimal Cutting 
Temperature media (OCT) and flash frozen in liqud N2. 10µm cryosections were then taken, 
which were stained with antibodies against Collagen I (ab34710, Abcam), with Hoescht 
33342 for nuclear counterstaining. Mineralization was assessed in 25µm sections using Von 
Kossa staining. For immunoblot analysis of osteogenesis-related signaling in cells, day 7 
void-forming hydrogels were removed from culture and washed with PBS. Next, cells were 
retrieved from hydrogels via calcium chelation with ice-cold 500mM EDTA. Cell pellets 
were washed in the same 500mM EDTA solution, and the pellets were flash-frozen in liquid 
nitrogen. Cells were lysed directly into SDS sample buffer, and 50 µg of protein were 
resolved by SDS-PAGE, transferred to a nitrocellulose membrane and then probed with 
antibodies against phospho-MAPK Thr202/Tyr204 (Cell Signaling, #9101) or total MAPK 
(Cell Signaling, #4696). GAPDH (Millipore, #Mab374) was used as a loading control.
In vitro Cell Deployment and Proliferation Studies
D1 mesenchymal stem cells (passages 20–24) were encapsulated into the bulk gel phase (2 
million cells/mL of bulk gel) by mixing with polymer before addition of porogen beads and 
crosslinking. Immediately after crosslinking, composite hydrogels were transferred to tissue 
culture polystyrene substrates with DMEM containing 10% Fetal Bovine Serum and 1% 
Penicillin/Streptomycin. Every 3–7 days, hydrogels were transferred aeseptically to fresh 
media in a fresh tissue culture plate. Care was taken to avoid damaging hydrogels during 
transfer. Wells in the used plate were washed with PBS and then deployed cells that had 
adhered to the substrate were quantified via alamar blue assay (Invitrogen). A standard curve 
formed by plating serial dilutions of D1 cells was used to convert alamar blue reduction rates 
into cell numbers. The validity of this approach was tested at early time-points through 
direct comparison of cell counts obtained by alamar blue to cell counts obtained by 
trypsinizing cells and counting with a hemocytometer (fig. S3).
In vivo Cell Deployment Studies
All animal studies were performed under protocols approved by institutional guidelines 
(Harvard University Institutional Animal Care and Use Committee). D1 cells were 
transduced using pOC-mCherry retrovirus10. Cells were then encapsulated into the bulk 
phase of void-forming hydrogels, and composite gels were injected (2×106 cells per 100µL 
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injection) into the subcutaneous space in the flank of Nu/J mice (Jackson) via 18-gauge 
needles. Each mouse received two bilateral injections. Over the time-course of the study, the 
overall level of mCherry fluorescence, proportional to cell density, was measured using a 
Caliper Life Sciences IVIS Xenogen imaging system. Animals were anesthetized with 
isofluorane during imaging procedures. All animal experiments were performed according 
to established animal protocols. For studies of cell deployment within cranial defects, 8-mm 
critical-sized cranial defects were formed in Nude Rats (Charles River), and a constant 
volume of hydrogel (100µL) containing 2 million mCherry-expressing D1 was injected 
directly into the freshly formed defect. One week after transplantation, animals were 
euthanized, mineralized bone was decalcified (EDTA), and histologic sections were acquired 
which encompassed the defect area. Transplanted D1 were identified by 
immunohistochemical staining for mCherry (AbCam, 10µG/mL) visualized by DAB 
chromogen (Thermoscientific) on a background of tissue stained with hematoxylin.
Cranial Defect Studies
Human MSC (Lonza) were propagated in low glucose DMEM with 20% FBS and 1% 
Penicillin/Streptomycin to passage 2–6. Subsequently, cells were encapsulated into the bulk 
phase of void-forming hydrogels or standard hydrogels, or mixed into saline. Cranial defects 
were formed as described above, and a constant volume of hydrogel or saline (100µL) 
containing 2 million hMSC was delivered into the freshly formed defects. After the 
surgeries, animals were encoded so that microcomputed tomography (µCT) and histology 
could be performed in a blinded fashion. Animals were euthanized after 12 weeks, and bone 
regeneration was detected using (µCT) on a Viva40 micro-CT (Scanco Medical , AG®), at a 
voltage of 55 kV and current of 145 μA, integration time of 314 ms. Voxel size was selected 
to be isotropic and fixed at 35.5 µm. The scan axis was adjusted to be normal to the subject 
frontal plane. An established protocol for quantitative analysis of µCT scans was used to 
obtain measurements of bone volume and average mineral density of newly formed mineral 
within defects (ref. 47).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Fabrication and characterization of void-forming hydrogels
(a). Schematic of the strategy to create void-forming hydrogels. Porogens (red) and 
mesenchymal stem cells (green) are co-encapsulated into a bulk hydrogel (grey). Pores 
(white) form within the intact bulk hydrogel due to porogen degradation, allowing cell 
deployment out of the material and into damaged tissues. Note that the rate of cell migration 
out of the material is expected to be a function of the distance of the cells from the newly 
formed pores. (b-e). Characterization of void-forming hydrogels. (b). Confocal micrographs 
of aminofluorescein-labeled porogens (green) within a rhodamine labeled bulk gel (red), 
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over the time-course of porogen degradation. (c-d). Quantative analysis of the total level of 
fluorescein, proportional to porogen density, either (c) remaining within gels, or (d) 
dissolved into media bathing gels. Gels were dissolved into EDTA at set time points to 
quantify remaining label. (e). Relative shear modulus G’ of void-forming hydrogels as a 
function of volume fraction of porogen, 1 week after hydrogel fabrication. Values of G’ are 
normalized to the value obtained for a standard hydrogel (no porogen) at day 1. Effects of 
porogen volume fraction on composite shear modulus were significant (p < 0.05, 1-way 
ANOVA). (f). Morphology of Calcein-AM stained mMSC in standard hydrogels (top) or in 
void-forming hydrogels (bottom) at day 4 and 10 after encapsulation (dotted blue line 
denotes void location). To right: 3D projections of Calcein-AM stained cells within either 
standard gels (top) or void-forming gels (bottom) after 40 days of in vitro culture. (g). 
Representative confocal micrograph of mMSC stained with phalloidin (green, with Hoescht 
33342 nuclear counterstain, blue) in situ within standard (top) and void forming gel (bottom) 
at day 7. (h) Representative micrographs depicting Ki67 expression (green, with Hoescht 
33342 nuclear counterstain, blue) in 10µm cryosections of mMSC in either standard gels 
(top) or void-forming gels (bottom) at day 7. (i) 24 hr 3H-thymidine incorporation by mMSC 
either in standard gels or void-forming hydrogels 1 week after encapsulation. (j) 24 hr 3H-
thymidine incorporation by mMSC in void-forming hydrogels wherein the bulk component 
had a varied level of integrin-binding RGD peptides. RGD density had a significant effect 
on 3H-incoproration (1-way ANOVA). Error bars are SD, n = 4 scaffolds. * p < 0.05, **** p 
< 0.001, 2-tailed t-test. Scale bars: b,c: 1mm (b inset: 200µm); f,h: 100µm; g: 20µm.
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Figure 2. Manipulating Stem Cell Osteogenesis and Proliferation by Controlling the Elasticity of 
the Bulk Phase of Void-Forming Hydrogels
(a). 3H-thymidine incorporation in last 24 hr by mMSC, after 7 days of culture in void-
forming hydrogels, as a function of the elastic modulus of the bulk component. RGD density 
of gels was constant (375µM). (b). Analysis of Alkaline Phosphatase (ALP; osteogenic 
biomarker) activity, normalized to the DNA density of mMSC deployed from void forming 
hydrogels of varying bulk elastic modulus (375µM RGD). Analysis was performed on cells 
that were released between days 7 and 14 of culture under osteogenic conditions. Bulk gel 
elasticity had significant effects (one-way ANOVA) on both proliferation and ALP activity. 
(c-d). Immunoblot analysis of MAPK phosphorylation (anti Phospho-p44/42 MAPK, 
Thr202/Tyr204) and total MAPK expression for mMSC within void-forming hydrogels as a 
function of bulk component elasticity, 7 days after gel formation, as depicted by (c) a 
representative blot and (d) quantitative analysis. GAPDH was used as a loading control for 
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Western Blots. (e-h). Analysis of (e,f-g,h) Collagen I expression (green; Hoescht 33342 
nuclear counterstain, blue) via antibody staining, and analysis of mineralization (f) via Von 
Kossa staining, of mMSC within void-forming hydrogels of varying bulk component 
elasticity, after 14 days of culture under osteogenic conditions. (g-h). Quantification of 
average Collagen I fluorescence signal from 16 cellular regions within the material either (g) 
without or (h) with normalization to the number of nuclei in each region. Matrix elasticity 
had a significant effect on Collagen I levels (ANOVA). Error bars: SD, n = 3–5 biologic 
replicates. * p < 0.05, compared to 5 kPa condition, Holm Bonferroni test, or p < 0.05 by 2-
way t-test with Holm Bonferonni correction for multiple comparisons. Scale bars: d,e: 
400µm.
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Figure 3. Controlling cell deployment kinetics from void-forming hydrogels in vitro and in vivo
(a). Kinetic analysis of murine mesenchymal stem cell (mMSC) deployment either from ( ) 
the bulk phase of void-forming hydrogels, or from standard nanoporous hydrogels (▲).The 
black line denotes the number of cells initially encapsulated into each scaffold. Difference in 
net cell deployment between the two types of hydrogels was statistically significant (p < 
0.01, 2-tailed t-test) at all time-points. (b-c). Kinetics of mMSC deployment from the bulk 
phase of void-forming hydrogels as a function of porogen degradation rate, as manipulated 
by controlling (b) the degree of oxidation of polymers used to form porogens (3% (▲), 5% 
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( ) or 7.5% ( )), or (c) the concentration of calcium (25mM (●), 50mM ( ) or 100mM 
( )) used to crosslink porogens. Net cell deployment was significantly greater from 
materials with porogens comprised by 7.5% degree of oxidation (p < 0.001 at all time points 
after day 0 by Holm-Bonferonni) compared to deployment from materials with either 3 or 
5% degree of oxidation. Each degree of porogen crosslinking yielded a level of net 
deployment that was statistically unique amongst the different materials tested at all time 
points after day 0 (Holm-Bonferonni test). (d) Analysis of net mMSC deployment at day 7, 
as a function of the elasticity of bulk component of void-forming gels. Elasticity had a 
significant effect (1-way ANOVA) on cell deployment. (e). Cumulative cell deployment for 
mMSC after 1 week of culture in void-forming gels with varying density of RGD peptides. 
(f). Representative images of Nu/J mice either 7 (top) or 30 (bottom) days after injection of 
standard (left) or pore-forming hydrogels (right) containing mCherry-expressing mMSC into 
the subcutaneous tissues of Nu/J mice. (g). Total radiant efficiency (proportional to cell 
number) from mCherry-mMSC injected within the following hydrogels: void-forming gels 
with porogens crosslinked with either 100mM ( ) or 50mM ( ) Ca2+, or within standard 
hydrogels (▲). Release of cells from either void-forming hydrogel yielded significantly 
more release than from a standard hydrogel at all time-points beginning at day 10, and 
altering porogen fabrication yielded a significant effect on radiant efficiency beginning on 
day 17 (p < 0.05, 2-tailed t-test). RGD density was fixed at 187µM in the bulk gel phase. (h). 
Total radiant efficiency resulting from mCherry-mMSC injected within void-forming 
hydrogels in which the RGD concentration was either ( )187µM or ( ) 750µM within the 
bulk phase, or within standard hydrogels (▲). Cell transplantation within either void-forming 
hydrogel type led to substantially higher total radiant efficiency at all time points after day 
12 (187µM RGD) or 19 (750µM RGD), compared to transplantation within standard 
hydrogels. The difference in total radiant efficiency was affected by the density of RGD 
presented by the bulk phase beginning on day 24 (p < 0.05). (i-j) Representative 
micrographs of tissues in Nude rat cranial defects one week after transplanting mCherry-
mMSC with either i) void-forming or j) standard hydrogels. mCherry antigen was probed 
with DAB chromogen. Error bars are SEM, n = 3–4 scaffolds (in vitro studies) or n = 4–8 
scaffolds (in vivo studies). Scale bar: g,h: 100µm.
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Figure 4. Matrix elasticity regulates mesenchymal stem cell mediated bone regeneration
(a-b). Analysis of bone regeneration in cranial defects due to hMSC transplantation via 
saline bolus, standard hydrogels or void-forming hydrogels. (a). Representative Micro-
Computed Tomographic (µCT) images of regeneration in cranial defects in nude rats 12 
weeks after introducing human MSC (hMSC) in saline (Cells Alone), within standard 
hydrogels or within void-forming hydrogels. (b). Quantitative analysis of the total volume of 
newly formed bone tissue using µCT. (c-j). Analysis of bone regeneration in cranial defects 
due to hMSC transplanted in void-forming hydrogels with different bulk-component elastic 
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moduli. (c). Representative Micro-Computed Tomographic (µCT) images of regeneration in 
nude rat cranial defects 12 weeks after hMSC delivery in void-forming hydrogels of varying 
bulk component moduli. (d-e). Quantitative analysis of (d) total volume and (e) average 
bone mineral density of regenerated bone. (f). Representative histologic analysis of new 
bone formation and remaining polymer with Hematoxyln-Eosin staining. (g). Representative 
Masson’s Trichrome staining depicting new bone formation. (h-j). High resolution 
micrographs depicting trichrome staining of a portion of newly regenerated tissue derived 
from hMSC transplanted in void forming gels with a bulk modulus of 60 kPa. (h) Entire sub-
section. (i-j). High resolution images depicting (i) osteoblast-like cells at the edge of newly 
forming tissue, and (j) osteocyte-like cells in the central part of newly formed tissues 
(denoted by black arrows). Error bars: SD, n = 4–5. ** p < 0.05, 2-tailed t-test. Scale bars: f-
h: 100µm; i-j: 20µm.
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